Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
PDF 24kWORD 22k
11 June 2019
E-001746/2019(ASW)
Answer given by Mr Moedas on behalf of the European Commission
Question reference: E-001746/2019

In order to enable its programme to be developed in a participatory manner, the health cluster foreseen under Pillar 2 of Horizon Europe and its six intervention areas are described at an aggregate level (i.e. with no disease specifications, nor earmarked resources). This will be further detailed in the strategic plan (see below). Building on this, Horizon Europe will follow work programmes, details of which will also be co-designed with Member States, stakeholders and citizens. Therefore, with such an open set-up, mental health can reasonably expected to be addressed.

To prepare the first strategic planning and programming process for Horizon Europe, all stakeholders, civil society and the wider public will be invited to contribute to and co-design its strategic orientations and priorities. In particular, they will be invited to respond to a public online consultation that will be open from June to September 2019 and to take part in the first European Research and Innovation Days(1) event on 24-26 September 2019 in Brussels. Both will serve to debate and direct Horizon Europe’s strategy and focus for the first four years (2021-2024). The Member States’ health ministries will also have an opportunity to contribute to the strategic debate via the Commission’s Steering Group on Health Promotion, Disease Prevention and Management of Non-Communicable Diseases. Taking part in these initiatives is the best way to ensure that stakeholders’ priorities will be heard and potentially addressed.

(1)https://ec.europa.eu/info/research-and-innovation/events/upcoming-events/european-research-and-innovation-days_en

Last updated: 13 June 2019Legal notice